Research progress of liposome drug delivery system in the treatment of head and neck cancer.
10.13201/j.issn.2096-7993.2025.01.019
- Author:
Bo LIU
1
;
Yaqin TU
1
;
Nan WU
1
;
Hongjun XIAO
1
Author Information
1. Department of Otorhinolaryngology，Union Hospital of Tongji Medical College of Huazhong University of Science and Technology，Wuhan，430022，China.
- Publication Type:English Abstract
- Keywords:
cancer treatment;
drug delivery systems;
head and neck cancer;
liposomes
- MeSH:
Humans;
Liposomes;
Head and Neck Neoplasms/drug therapy*;
Drug Delivery Systems;
Antineoplastic Agents/administration & dosage*
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(1):91-96
- CountryChina
- Language:Chinese
-
Abstract:
Head and neck tumors are one of the major diseases that threaten human health. Targeted chemotherapy is an important treatment for head and neck tumors. However, many anti-cancer drugs are difficult to reach effective concentrations in tumors and can cause damage to normal tissues. Therefore, the efficient delivery of anti-tumor drugs, improvement of their therapeutic effects, and reduction of their adverse effects on the whole body and locally are urgent issues in targeted drug research. Liposomes have been widely studied due to their unique characteristics, including amphiphilicity, biocompatibility, biodegradability, and low toxicity. This article outlines the current applications and prospects of liposome drug delivery systems in different treatment modalities for head and neck tumors in recent years, aiming to provide more options for the treatment of head and neck tumors.
